ANXA5 and ovarian cancer: According to analysis of flow cytometry using an annexin V-TITC and PI double-staining method, PGPIPN could significantly promote the apoptosis of resistant cell lines (SKOV3/DDP and COC1/DDP) and human primary ovarian cancer cells inducing by DDP for 48 h, which displayed dose-dependent manners (Figure 3).